Skip to content

A Multi-center Trial of Single-Branched Stent Graft System to Treat Aortic Dissection

A Multi-center Trial of Castor Single-Branched Stent Graft System for Endovascular Repair of Aortic Dissection.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01914237
Enrollment
70
Registered
2013-08-02
Start date
2013-04-30
Completion date
2017-04-30
Last updated
2013-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal Aortic Dissection

Keywords

Single-Branched Stent Graft System, Aortic Dissection, Endovascular Repair

Brief summary

Aim:Castor is a novel single-branched stent graft system for endovascular repair of aortic arch dissection. This is a prospective, one-arm, open, multi-center, pre-market study of Castor stent to evaluate its efficacy and safety in treatment of aortic dissection. Number of patients: 70 patients will be included and undertaken endovascular repair with Castor stent. Follow-up: 1.aortic computed tomographic angiography (CTA) examination 6 and 12 months after the surgery 2.telephone or clinical follow-up 30 days and 2-5 years after the surgery Primary Outcome Measure: success rate of endovascular repair for efficacy measurement. Secondary Outcome Measure: 1 year stent related adverse event rate for safety measurement. Other Outcome Measures: 1. efficacy: * 1 year success rate of treatment * 1 year patency rate of branch stent 2. safety: * in-hospital mortality * complication rate of neural system * 1 year dissection or stent related mortality

Interventions

DEVICECastor Stent Graft

Endovascular Repair of Aortic Dissection

Sponsors

Fudan University
CollaboratorOTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
CollaboratorOTHER
Central South University
CollaboratorOTHER
Beijing Anzhen Hospital
CollaboratorOTHER
Peking Union Medical College Hospital
CollaboratorOTHER
Peking University People's Hospital
CollaboratorOTHER
Chinese PLA General Hospital
CollaboratorOTHER
The Second Affiliated Hospital of Harbin Medical University
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
Nanjing PLA General Hospital
CollaboratorOTHER
First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Shandong Provincial Hospital
CollaboratorOTHER_GOV
The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
Xijing Hospital
CollaboratorOTHER
China Medical University, China
CollaboratorOTHER
First Affiliated Hospital of Chongqing Medical University
CollaboratorOTHER
Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* age from 18 to 80, male or unpregnant female * diagnosed as aortic dissection * proximal tear of the dissection locates between 15mm to the distal end of left common carotid artery and 20mm to the distal end of left subclavian artery (LSA) or inverse tear to LSA * good compliance with the instructions and cooperate with follow-up * voluntarily signed the informed consent form

Exclusion criteria

* Pregnant female * no appropriate vessel approaches * patients with connective tissue diseases (such as Marfan syndrome) * allergic to nitinol or contrast medium * bad compliance with the instructions and follow-up * estimated remaining life is less than 12 months

Design outcomes

Primary

MeasureTime frameDescription
success rate of endovascular repairduring the surgery\- during the surgery: successful conduction, accurate positioning and release, and no warping, folding, narrowing or blocking of the stent graft system. Immediately after the stent release, angiography shows both main stent and side arm stent patency, successful exclusion of dissection and no arteriorrhexis or dissection rupture.

Secondary

MeasureTime frameDescription
1 year stent related adverse event rate1 year* unexpected breakage and shifting of the stent * type I or type III endoleak which needs intervention * dissection rupture around the stent

Other

MeasureTime frameDescription
in-hospital mortalityparticipants will be followed for the duration of hospital stay, an expected average of 1 weekmortality of patients caused by dissection related postoperative complications before discharge.
1 year success rate of treatment1 year* complete exclusion of the dissection * no dissection rupture * no type I or type III endoleak which needs twice intervention * false lumen of aorta around stent graft closed with thrombus
1 year dissection or stent related mortality1 year1 year dissection or stent related mortality
complication rate of neural system2 yearscomplication rate of neural system related to the stent graft
1 year patency rate of branch stent1 yearThe incidence of more than 50% branch stent patency

Countries

China

Contacts

Primary ContactZaiping JING, MD
jingzp@xueguan.net86-21-31166666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026